TrialThe lancet. Diabetes & endocrinology2019

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial.

Vanita R Aroda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.